157 related articles for article (PubMed ID: 36242824)
1. The use of early neuromuscular blockage in acute respiratory distress syndrome: A systematic review and meta-analyses of randomized clinical trials.
Savoie-White FH; Tremblay L; Menier CA; Duval C; Bergeron F; Tadrous M; Tougas J; Guertin JR; Ugalde PA
Heart Lung; 2023; 57():186-197. PubMed ID: 36242824
[TBL] [Abstract][Full Text] [Related]
2. Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for Treatment of Acute Respiratory Distress Syndrome-A Retrospective Cohort Study From a New England Health Care Network.
Wongtangman K; Grabitz SD; Hammer M; Wachtendorf LJ; Xu X; Schaefer MS; Fassbender P; Santer P; Kassis EB; Talmor D; Eikermann M;
Crit Care Med; 2021 Jul; 49(7):1137-1148. PubMed ID: 33710031
[TBL] [Abstract][Full Text] [Related]
3. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults.
Dushianthan A; Cusack R; Burgess VA; Grocott MP; Calder PC
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012041. PubMed ID: 30677127
[TBL] [Abstract][Full Text] [Related]
4. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
Lyu T; Lee YS; Dhanvijay S; Freebairn R
Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological agents for adults with acute respiratory distress syndrome.
Lewis SR; Pritchard MW; Thomas CM; Smith AF
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD004477. PubMed ID: 31334568
[TBL] [Abstract][Full Text] [Related]
6. Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression.
Shao S; Kang H; Tong Z
BMJ Open; 2020 Nov; 10(11):e037737. PubMed ID: 33444180
[TBL] [Abstract][Full Text] [Related]
7. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
Alhazzani W; Alshahrani M; Jaeschke R; Forel JM; Papazian L; Sevransky J; Meade MO
Crit Care; 2013 Mar; 17(2):R43. PubMed ID: 23497608
[TBL] [Abstract][Full Text] [Related]
8. Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials.
Chang W; Sun Q; Peng F; Xie J; Qiu H; Yang Y
Crit Care; 2020 Feb; 24(1):54. PubMed ID: 32066488
[TBL] [Abstract][Full Text] [Related]
9. Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials.
Zheng Z; Jiang L; Zhang S; Guervilly C; Zhang M; Feng X; Ding J
Respir Res; 2020 Jan; 21(1):23. PubMed ID: 31931794
[TBL] [Abstract][Full Text] [Related]
10. Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis.
Hua Y; Ou X; Li Q; Zhu T
PLoS One; 2020; 15(1):e0227664. PubMed ID: 31961896
[TBL] [Abstract][Full Text] [Related]
11. Neuromuscular blockers in early acute respiratory distress syndrome.
Papazian L; Forel JM; Gacouin A; Penot-Ragon C; Perrin G; Loundou A; Jaber S; Arnal JM; Perez D; Seghboyan JM; Constantin JM; Courant P; Lefrant JY; Guérin C; Prat G; Morange S; Roch A;
N Engl J Med; 2010 Sep; 363(12):1107-16. PubMed ID: 20843245
[TBL] [Abstract][Full Text] [Related]
12. [Statin in the treatment of ALI/ARDS: a systematic review and Meta-analysis based on international databases].
Chen M; Lu J; Chen Q; Cheng L; Geng Y; Jiang H; Wang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):51-56. PubMed ID: 28459404
[TBL] [Abstract][Full Text] [Related]
13. Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials.
Tarazan N; Alshehri M; Sharif S; Al Duhailib Z; Møller MH; Belley-Cote E; Alshahrani M; Centofanti J; McIntyre L; Baw B; Meade M; Alhazzani W;
Intensive Care Med Exp; 2020 Oct; 8(1):61. PubMed ID: 33095344
[TBL] [Abstract][Full Text] [Related]
14. Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS).
Chacko B; Peter JV; Tharyan P; John G; Jeyaseelan L
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD008807. PubMed ID: 25586462
[TBL] [Abstract][Full Text] [Related]
15. Association of different positive end-expiratory pressure selection strategies with all-cause mortality in adult patients with acute respiratory distress syndrome.
Tisminetzky M; Dianti J; Ferreyro BL; Angriman F; Del Sorbo L; Sud S; Talmor D; Fan E; Ferguson ND; Serpa Neto A; Adhikari NKJ; Goligher EC
Syst Rev; 2021 Aug; 10(1):225. PubMed ID: 34384488
[TBL] [Abstract][Full Text] [Related]
16. Neuromuscular Blocking Agents for ARDS: A Systematic Review and Meta-Analysis.
Torbic H; Krishnan S; Harnegie MP; Duggal A
Respir Care; 2021 Jan; 66(1):120-128. PubMed ID: 32843506
[TBL] [Abstract][Full Text] [Related]
17. High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome.
Santa Cruz R; Villarejo F; Irrazabal C; Ciapponi A
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD009098. PubMed ID: 33784416
[TBL] [Abstract][Full Text] [Related]
18. Prone position for acute respiratory failure in adults.
Bloomfield R; Noble DW; Sudlow A
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008095. PubMed ID: 26561745
[TBL] [Abstract][Full Text] [Related]
19. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
Needham CJ; Brindley PG
Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
[TBL] [Abstract][Full Text] [Related]
20. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
